Roche and Genentech announce new clinical trial to begin early next year - Generation HD2 - to explore the use of tominersen in younger, less symptomatic HD patients. Click here…
Family Planning and Research Participation
HD-CARE board member and UCI researcher Dr. Sarah Hernandez recently published an article about family planning and research participation. Read more about it here.
Experimental Drug For Huntington’s Disease Jams Malfunctioning Gene
NPR’s All Things Considered discusses latest HD clinical trial on May 11. Listen or read more here.
Roche Phase 3 Clinical Trial for Huntington’s Disease Gene-Silencing Drug to Enroll Volunteers – Early 2019
Dear friends in the fight against Huntington's disease, Pharma giant Roche expects to start enrolling subjects worldwide (including the U.S.) in early 2019 in its historic Phase 3 clinical trial…